Latest financial and economic news and analysis
A break below $71.90 opens the door to $69, while a move above resistance may support a rally toward $94.
TPG Real Estate Finance Trust (TRTX) Series C Preferred (TRTX.PR.C) remains a Buy, supported by robust Q2 2026 financials and prudent portfolio management. TRTX has reduced office exposure to 4.3% and shifted toward multifamily and industrial assets, mitigating sector risk. Leverage increased to 3.3x, balanced by conservative underwriting and a capital structure reset with long-term, non-mark-to-market debt.
Philadelphia, Pennsylvania--(Newsfile Corp. - August 7, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against ADMA Biologics, Inc. (NASDAQ: ADMA) ("ADMA" or the "Company") on behalf of investors who purchased or acquired ADMA common stock during the period from August 9, 2024 through March 25, 2026 (the "Class Period"). Investor Deadline: Investors who purchased or acquired ADMA securities during the Class Period may, no later than August 10, 2026, seek to be appointed as a lead plaintiff representative of the class.
Gyre Therapeutics, Inc. (GYRE) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to earnings of $0.02 per share a year ago.
Johnson Outdoor (JOUT) came out with quarterly earnings of $1.42 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.75 per share a year ago.
ARKO Corp. (ARKO) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.16 per share a year ago.
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.27 per share a year ago.
Starz Entertainment Corp. (STRZ) came out with a quarterly loss of $1.26 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $2.23 per share a year ago.
Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.3. This compares to a loss of $0.28 per share a year ago.
Construction Partners (ROAD) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $0.81 per share a year ago.
US employers unexpectedly cut jobs in July and hiring over the previous two months was revised lower. 23,000 jobs were lost, the estimate was for a gain of 80,000 jobs.
The Labor Department reported that payrolls declined 23K in July, well below expectations of growth of nearly 100K. Unemployment, on the other hand, declined to 4.1%.
With trading volume rising by more than 116 percent over the last day as ADA surpassed the crucial $0.20 level, Cardano has produced one of its best sessions in weeks. Although the asset's bullish sentiment has been rekindled by the increase in activity, the technical picture indicates that the market still faces significant obstacles before a long-term bull run can start.
Base's dominance in on-chain Bitcoin trading highlights a rapid market consolidation, challenging competitors and reshaping the crypto landscape. Base records $4B in spot Bitcoin trading in July, capturing half of all on-chain volume.
Gold and silver just posted their strongest week of 2026. Bitcoin (BTC) sat it out.
